Bolt Biotherapeutics Inc (BOLT)
1.11
0.00 (0.00%)
USD |
NASDAQ |
May 09, 10:28
Bolt Biotherapeutics Price to Book Value: 0.3754 for May 9, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 08, 2024 | 0.3754 |
May 07, 2024 | 0.3652 |
May 06, 2024 | 0.372 |
May 03, 2024 | 0.372 |
May 02, 2024 | 0.372 |
May 01, 2024 | 0.3788 |
April 30, 2024 | 0.3737 |
April 29, 2024 | 0.3788 |
April 26, 2024 | 0.3754 |
April 25, 2024 | 0.3923 |
April 24, 2024 | 0.4059 |
April 23, 2024 | 0.3754 |
April 22, 2024 | 0.3754 |
April 19, 2024 | 0.3754 |
April 18, 2024 | 0.3855 |
April 17, 2024 | 0.3754 |
April 16, 2024 | 0.3889 |
April 15, 2024 | 0.3822 |
April 12, 2024 | 0.4058 |
April 11, 2024 | 0.4295 |
April 10, 2024 | 0.4227 |
April 09, 2024 | 0.4346 |
April 08, 2024 | 0.4633 |
April 05, 2024 | 0.4498 |
April 04, 2024 | 0.4498 |
Date | Value |
---|---|
April 03, 2024 | 0.4566 |
April 02, 2024 | 0.4735 |
April 01, 2024 | 0.5073 |
March 28, 2024 | 0.4735 |
March 27, 2024 | 0.4126 |
March 26, 2024 | 0.4024 |
March 25, 2024 | 0.4058 |
March 22, 2024 | 0.4058 |
March 21, 2024 | 0.3923 |
March 20, 2024 | 0.3923 |
March 19, 2024 | 0.3889 |
March 18, 2024 | 0.3855 |
March 15, 2024 | 0.3754 |
March 14, 2024 | 0.372 |
March 13, 2024 | 0.3906 |
March 12, 2024 | 0.4243 |
March 11, 2024 | 0.4277 |
March 08, 2024 | 0.4479 |
March 07, 2024 | 0.4209 |
March 06, 2024 | 0.4209 |
March 05, 2024 | 0.4142 |
March 04, 2024 | 0.4277 |
March 01, 2024 | 0.4075 |
February 29, 2024 | 0.3839 |
February 28, 2024 | 0.4007 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2313
Minimum
May 06 2022
3.943
Maximum
Mar 31 2021
0.7198
Average
0.377
Median
Jan 17 2024
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.920 |
Palatin Technologies Inc | -- |
iBio Inc | 0.7084 |
Theriva Biologics Inc | 0.2018 |
Oragenics Inc | 3.555 |
Price to Book Value Related Metrics
PS Ratio | 5.329 |
Price | 1.11 |
Earnings Yield | -164.9% |
Market Cap | 42.32M |